APA (7th ed.) Citation

Geis, N., Kiriakou, C., Chorianopoulos, E., Pleger, S. T., Katus, H., & Bekeredjian, R. (2017). Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation. EuroIntervention, 12(17), . https://doi.org/10.4244/EIJ-D-15-00259

Chicago Style (17th ed.) Citation

Geis, Nicolas, Christina Kiriakou, Emmanuel Chorianopoulos, Sven Torsten Pleger, Hugo Katus, and Raffi Bekeredjian. "Feasibility and Safety of Vitamin K Antagonist Monotherapy in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Implantation." EuroIntervention 12, no. 17 (2017). https://doi.org/10.4244/EIJ-D-15-00259.

MLA (9th ed.) Citation

Geis, Nicolas, et al. "Feasibility and Safety of Vitamin K Antagonist Monotherapy in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Implantation." EuroIntervention, vol. 12, no. 17, 2017, https://doi.org/10.4244/EIJ-D-15-00259.